IMMUNETICS, INC.

BOSTON, MA · CIK 0001056227 · Medtech · Acquired

Babesia microti antigen detection assay for blood donor screening

immunetics.com →
Grants
$21M
15 awards
Sector median: 1
Raised
$1.5M
2 Form D · Mar 2014
151 months since last filing
Contracts
$4.0M
7 awards · Veterans Affairs, Health and Human S
#142 of 4531 in medtech
Patents
17
5 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Veterans Affairs · LYMEC6 Kit$1,063
Federal contractDepartment of Veterans Affairs · Blank$1,499
Federal contractDepartment of Veterans Affairs · Blank$1,069
Federal contractDepartment of Health and Human Services · M-27358 00HCVGDE-2008-60217.01 - Immuneticsquickelisa Prototypes$52,200
Federal contractDepartment of Health and Human Services · 200-2008-M-27800 Immunetics$51,999
Federal contractDepartment of Health and Human Services · TAS::75 0872::TAS Screening And Confirmatory Tests For Human Babesia SBIR Phase I Rfp No Phs 2010-1 Topic 56$217,479
Private capital raisedForm D · SEC$629,090
Federal contractDepartment of Health and Human Services · Igf::ot::igf Rd-sbir Topic 56 Phase II Immunetics$3,667,659
Private capital raisedForm D · SEC$835,000
Federal grantDepartment of Health and Human Services · Phase II · Rapid, Near-Tranfusion Test for Bacteria in Platelets Units$989,098
Federal grantDepartment of Health and Human Services · Phase II · Molecular Detection of Invasive Fungal Infections$2,981,715
Federal grantDepartment of Health and Human Services · Phase II · Immunoassay for diagnosis of Babesia infection$3,612,039
Federal grantDepartment of Health and Human Services · Phase II · Rapid point of care test for Lyme serodiagnosis based on novel ultra sensitive de$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Babesia antigen detection assay for blood screening$3,602,440
Federal grantDepartment of Health and Human Services · Phase II · Rapid Test for Recent HIV Infection$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Supplement to cover cost of participation in BIO Innovation Zone Exhibit$5,000
Federal grantDepartment of Health and Human Services · Phase II · Rapid, Near-Tranfusion Test for Bacteria in Platelets Units$972,241
Federal grantDepartment of Health and Human Services · Phase II · Molecular Detection of Invasive Fungal Infections$999,952
Federal grantDepartment of Health and Human Services · Phase II · Rapid point of care test for Lyme serodiagnosis based on novel ultra sensitive de$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Immunoassay for diagnosis of Babesia infection$808,595
Federal grantDepartment of Health and Human Services · Phase II · Rapid Test for Recent HIV Infection$976,061
Federal grantDepartment of Health and Human Services · Phase II · Babesia antigen detection assay for blood screening$995,189
Federal grantDepartment of Health and Human Services · Phase II · Molecular Detection of Invasive Fungal Infections$988,975
Federal grantDepartment of Health and Human Services · Phase II · Babesia antigen detection assay for blood screening$990,061
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
139Neurable Inc.$4.1M$12M
140DXDISCOVERY INC$4.1M—
141SUVICA INC$4.0M—
142IMMUNETICS, INC.$4.0M$1.5M
143SWITCHBOX INC$4.0M—
144Springactive, Inc.$3.8M—
145Mattek Corporation$3.8M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 15 related persons
  • Stephen ChubbDirector
  • STEPHEN CHUBBDirector
  • Richard GibbsDirector
  • RICHARD GIBBSDirector
  • Andrew LevinDirector · Executive Officer
  • ANDREW LEVINDirector · Executive Officer
  • Richard PinkowitzExecutive Officer
  • RICHARD PINKOWITZExecutive Officer
  • Lois SilvermanDirector
  • LOIS SILVERMANDirector
  • John YonkinDirector · Executive Officer
  • Houry YoussoufianExecutive Officer
  • HOURY YOUSSOUFIANExecutive Officer
  • Ron ZwanzigerDirector
  • RON ZWANZIGERDirector

Patents

USPTO · 5 granted of 17

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.